Financial Resources
The business model of Rare Partners implies that the necessary financial resources for the development of new therapies will be identified and allocated in collaboration with the academic or industrial partner.
Through the years the Regional, National and European programs supporting research and development activities have been the main financial source for the ongoing projects. Also International non profit organizations, such as Wellcome Trust Foundation, played an important role in financing some our projects.
Moreover, Rare Partners regularly organizes fund raising campaigns, often associated to sport events, in order to finance the ongoing projects as well as the structural company costs. The latters have been historically maintained to a very low level, thanks to the absence of own laboratories and to the “pro bono” collaboration from the professionals involved in the company’s network.